Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-29

Clinical Trial Update: Ozurdex as Adjunct to Avastin Compared to Avastin Alone in Treatment of Patients With Diabetic Macular Edema [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Ozurdex added to Avastin versus Avastin alone in diabetic macular edema; results completed and posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avastin (bevacizumab)
  • Ozurdex (dexamethasone intravitreal implant)

Snippet

Sponsor: Maturi, Raj K., M.D., P.C. | Conditions: Diabetic Macular Edema | Phase 4 | Status: COMPLETED | Results posted: 2014-10-29